These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 20884288)
1. Novaprep(®) Vial Test is a suitable liquid-based cytology medium for high risk human papillomavirus testing by Hybrid Capture 2. Prétet JL; Vidal C; Le Bail Carval K; Ramanah R; Carcopino X; Cartier I; Labouyrie E; Kantelip B; Coumes-Marquet S; Riethmuller D; Mougin C J Clin Virol; 2010 Dec; 49(4):286-9. PubMed ID: 20884288 [TBL] [Abstract][Full Text] [Related]
2. Hybrid capture as a means of detecting human papillomavirus DNA from liquid-based cytology specimens: a preliminary evaluation. Callaghan J; Karim S; Mortlock S; Wintert M; Woodward N Br J Biomed Sci; 2001; 58(3):184-9. PubMed ID: 11575742 [TBL] [Abstract][Full Text] [Related]
3. The next-generation Hybrid Capture High-Risk HPV DNA assay on a fully automated platform. Eder PS; Lou J; Huff J; Macioszek J J Clin Virol; 2009 Jul; 45 Suppl 1():S85-92. PubMed ID: 19651374 [TBL] [Abstract][Full Text] [Related]
4. Dutch solutions for liquid-based cytology: analysis of unsatisfactory slides and HPV testing of equivocal cytology. Boon ME; Rijkaart DC; Ouwerkerk-Noordam E; Korporaal H Diagn Cytopathol; 2006 Sep; 34(9):644-8. PubMed ID: 16900471 [TBL] [Abstract][Full Text] [Related]
5. Validation of ThermoFisher's Papspin for human papillomavirus detection in cervicovaginal specimens using PCR with GP5+/GP6+ primers and the Hybrid Capture II assay. Weynand B; Delvenne P; Polet R; Guiot Y; Arafa M; Somja J; Galant C Clin Microbiol Infect; 2010 Jun; 16(6):671-5. PubMed ID: 19689463 [TBL] [Abstract][Full Text] [Related]
6. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology. Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375 [TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus detection: verification with cervical cytology. Matthews-Greer J; Rivette D; Reyes R; Vanderloos CF; Turbat-Herrera EA Clin Lab Sci; 2004; 17(1):8-11. PubMed ID: 15011974 [TBL] [Abstract][Full Text] [Related]
8. Development of optimal liquid based cytology sample processing methods for HPV testing: minimising the 'inadequate' test result. Peevor R; Jones J; Fiander AN; Hibbitts S J Virol Methods; 2011 May; 173(2):374-7. PubMed ID: 21295606 [TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening. Bidus MA; Maxwell GL; Kulasingam S; Rose GS; Elkas JC; Chernofsky M; Myers ER Obstet Gynecol; 2006 May; 107(5):997-1005. PubMed ID: 16648402 [TBL] [Abstract][Full Text] [Related]
10. [Detection of human papillomavirus infection by the nucleic acid hybridization method (a multicenter study)]. Deák J; Cseh I; Szöllösi J; Pulay T; Kornya L; Bak M; Nyári T; Weszelovszky E; Kalmár L; Jakab I; Jármai J; Nagy E; Kovács L Orv Hetil; 1999 Jan; 140(3):115-20. PubMed ID: 9990815 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the clinical performance of the Abbott RealTime High-Risk HPV for carcinogenic HPV detection. Halfon P; Benmoura D; Agostini A; Khiri H; Penaranda G; Martineau A; Blanc B J Clin Virol; 2010 Aug; 48(4):246-50. PubMed ID: 20541966 [TBL] [Abstract][Full Text] [Related]
12. Efficiency of the hybrid capture 2 HPV DNA test in cervical cancer screening. A study by the French Society of Clinical Cytology. de Cremoux P; Coste J; Sastre-Garau X; Thioux M; Bouillac C; Labbé S; Cartier I; Ziol M; Dosda A; Le Galès C; Molinié V; Vacher-Lavenu MC; Cochand-Priollet B; Vielh P; Magdelénat H; Am J Clin Pathol; 2003 Oct; 120(4):492-9. PubMed ID: 14560561 [TBL] [Abstract][Full Text] [Related]
13. High-risk HPV detection in specimens collected in SurePath preservative fluid: comparison of ambient and refrigerated storage. Hardie A; Moore C; Patnick J; Cuschieri K; Graham C; Beadling C; Ellis K; Frew V; Cubie HA Cytopathology; 2009 Aug; 20(4):235-41. PubMed ID: 19659956 [TBL] [Abstract][Full Text] [Related]
14. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing. Sherman ME; Schiffman MH; Lorincz AT; Herrero R; Hutchinson ML; Bratti C; Zahniser D; Morales J; Hildesheim A; Helgesen K; Kelly D; Alfaro M; Mena F; Balmaceda I; Mango L; Greenberg M Cancer; 1997 Apr; 81(2):89-97. PubMed ID: 9126136 [TBL] [Abstract][Full Text] [Related]
15. The evaluation of human papillomavirus genotyping in cervical liquid-based cytology specimens; using the Roche Linear Array HPV genotyping assay. Jamison J; Wilson RT; Carson J Cytopathology; 2009 Aug; 20(4):242-8. PubMed ID: 19291176 [TBL] [Abstract][Full Text] [Related]
17. Very low human Papillomavirus DNA prevalence in mature women with negative computer-imaged liquid-based Pap tests. Zhao C; Elishaev E; Yuan KH; Yu J; Austin RM Cancer; 2007 Oct; 111(5):292-7. PubMed ID: 17879368 [TBL] [Abstract][Full Text] [Related]
18. HPV mRNA test in women with minor cervical lesions: experience of the University Hospital of North Norway. Sorbye SW; Fismen S; Gutteberg TJ; Mortensen ES J Virol Methods; 2010 Oct; 169(1):219-22. PubMed ID: 20638416 [TBL] [Abstract][Full Text] [Related]
19. A peer comparison program for the quality assurance of human papillomavirus DNA detection using the Digene Hybrid Capture II/SurePath method shows excellent analytic interlaboratory correlation. Kuebler DL; Illingworth A; Blenc AM; Wilbur DC Cancer; 2007 Oct; 111(5):339-43. PubMed ID: 17879373 [TBL] [Abstract][Full Text] [Related]
20. Anal human papillomavirus testing with Digene's hybrid capture 2 using two different sampling methods. Roka F; Roka J; Trost A; Schalk H; Zagler C; Kirnbauer R; Salat A Dis Colon Rectum; 2008 Jan; 51(1):62-6. PubMed ID: 18030530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]